- Advertisement -
Tags GlaxoSmithKline

Tag: GlaxoSmithKline

Indivior releases new treatment, shares dip with copycat fears

FTSE 250 specialist pharmaceutical company Indivior Plc (LON:INDV) announced on Wednesday that it has released an authorised generic version of its treatment to combat...

GlaxoSmithKline profits up 36% – warnings for 2019

British pharmaceutical firm GlaxoSmithKline (LON:GSK) have posted a 36% on-year hike in full-year profits, though the company have warned investors of the potential for...

GSK secure approval for Nucala asthma treatment

GlaxoSmithKline Plc (LON:GSK) have secured approval for a licence extension of their Nucala treatment for children with severe asthma. The treatment was first received patent...

GlaxoSmithKline shares rally and buck the FTSE trend

GlaxoSmithKline (LON:GSK) continues to rally and avoid the more bleak fate being faced by some of its FTSE 100 counterparts. GSK's share price has progressed...

Most Read

IAG share price: good value if air travel returns to normal

The coronavirus pandemic devastated not only International Consolidated Airlines (IAG) (LON:IAG), but the airline sector more generally. Heathrow confirmed a £2bn loss during 2020...

GRIT Real Estate Income Group: exposure to Africa’s rapid growth

GRIT Real Estate Income Group is a leading pan-African property investment company with an actively managed and diversified portfolio of assets worth $849.2m. There are...